Skip to main content
CHRS $0.53 -2.41%
CHRS logo
CHRS · Coherus Oncology, Inc.
Track CHRS — free
$0.53 -0.01 (-2.41%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$81.21M
Shares
154.54M
Volume · Nov 13 4.31M Avg daily vol (3M) 1.69M
All webcasts

Earnings call · FY2024 Q2

Coherus Oncology, Inc. (CHRS) Q2 2024 Earnings Call

Concluded Aug 8, 2024
Aug 8, 2024
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
Revenue $10.30M -82.5% YoY
Diluted EPS -$0.11
Gross margin · derived Q4 82.4% +24.7 pp YoY
Net income -$12.92M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product And Service Other$6.51M +2412.4% YoY
Toripalimab$3.79M
Full-screen source Call document